-
Symbol
-
BBOT on Nasdaq
-
Investment type
-
Equity / COMMON STOCK
-
Latest Disclosed Shares Owned
-
4,365,747 shares
-
Security Ownership %
-
5.5%
BC Global Opportunities IX LP ownership in BridgeBio Oncology Therapeutics, Inc. COMMON STOCK (BBOT)
03 Sep 2025 - BC Global Opportunities IX LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,365,747 shares of BridgeBio Oncology Therapeutics, Inc. COMMON STOCK (BBOT).
This represents 5.5% ownership of the company.
This is the first filing by BC Global Opportunities IX LP disclosing ownership of BridgeBio Oncology Therapeutics, Inc. COMMON STOCK (BBOT).